Company: QTIWW
Filing Date: 2025-01-31
Form Type: S-1/A
Source: 0001628280-25-003316
Chunk: 15

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-01-31
Form: S-1/A
Chunk 15
---
 medical conditions without needing a healthcare “gate-keeper.”

• Focus our intellectual capabilities and ethical framework to become unified in our mission to improve the quality and lower the cost of health care world-wide... “It’s about time.”

#### Additional Material Agreements

#### Canon Letter of Intent
QT Imaging has entered into a non-binding letter of intent (the “ Canon Letter of Intent ”), with CMSU and Canon Medical Systems Corporation (“ CMSC ”), a company organized and existing under the laws of Japan, pursuant to which CMSC purchased and acquired two QT Breast Scanners in the first half of 2024. The Canon Letter of Intent provided that CMSC would conduct, and pursuant to the Feasibility Study Agreement (as described below), CMSC conducted, feasibility studies on the QT Breast Scanners that it acquired, including product quality validation, development and manufacturing studies, clinical evaluation, regulatory investigation and marketing validation (the “ Feasibility Study ”). The Feasibility Study was completed in the second half of 2024.

The Canon Letter of Intent provided that upon successful conclusion of the Feasibility Study, we and CMSC intended to engage in a good faith discussion to develop a binding original equipment manufacturing (“ OEM ”) agreement with CMSC.

CMSC will also use QT Breast Scanners that it acquired to perform clinical trials towards the possibility of it pursuing the regulatory approval process in Japan.

CMSC and QT Imaging have also discussed other potential terms between them.

Feasibility Agreement with Canon Medical Systems Corporation

On March 28, 2024, we entered into a Feasibility Study Agreement (the “ Feasibility Study Agreement ”) with CMSC. The term of the Feasibility Study Agreement commenced on March 28, 2024 and remained in force until the end of December 2024. In connection with the Feasibility Study Agreement, CMSC initiated studies to evaluate the business, technical, and clinical values of the QT Breast Scanner including product quality validation, development and manufacturing studies, clinical evaluation, regulatory investigation, and market validation. CMSC has no right to reverse engineer the QT Breast Scanner and may only modify and disassemble the QT Breast Scanner as necessary to conduct the Feasibility Study.

Under the terms of the Feasibility Study Agreement, we provided support for the Feasibility Study as agreed with CMSC from time to time during the term of the Feasibility Study Agreement and used our commercially reasonable efforts to facilitate the Feasibility Study.

All know-how and intellectual property embodied in